• Home
  • info@pubtexto.com
  • Contact Us
  • About Journal
  • Aim And Scope
  • Guidelines
    • Instructions For Authors
    • Editor Guidelines
    • Reviewer Guidelines
    • Copy Rights
  • Editorial Board
  • Submit Manuscript
  • Articles
    • Article In Press
    • Current Issue
    • Archives
  • Special Issue

Volume - 6, Issue - 1

Research article

Investigation of Irisin (Fndc5) Gene Polymorphisms in Patients with Gestational Diabetes Mellitus

Caska H, Akbas H and Sak S

Medicine: Int J Endocrinol Diabetes 2023, 6: 1

  • Abstract
  • View PDF
  • Full-Text HTML
Case Report

Early elderly male with type 2 diabetes (T2D) changed from metformin to imeglimin (Twymeeg)

Bando H, Okada M, Iwatsuki N, Sakamoto K and Ogawa T

Medicine: Int J Endocrinol Diabetes 2023, 6: 1

  • Abstract
  • View PDF
  • Full-Text HTML
Research article

Perinatal Outcomes in Gestational Diabetes in the Province Of Trento: A Study on Birth Cohorts 2017-2019

Piffer S, Rizzello R, Pedron M, Orrasch M, Zambotti F and Zardini S

Medicine: Int J Endocrinol Diabetes 2023, 6: 1

  • Abstract
  • View PDF
  • Full-Text HTML
Case Report

Effect of imeglimin (Twymeeg) on pre-prandial glucose in patient with persisting post-prandial hyperglycemia

Bando H, Kobayashi H, Ogawa H, Nagahiro S, Nakanishi M and Watanabe O

Medicine: Int J Endocrinol Diabetes 2023, 6: 1

  • Abstract
  • View PDF
  • Full-Text HTML
Minireview Article

The Association between Insulin Signaling, Type2 Diabetes, And Cognitive Dysfunction

Taguchi A

Medicine: Int J Endocrinol Diabetes 2023, 6: 1

  • Abstract
  • View PDF
  • Full-Text HTML

For Author

  • Open Access
  • Peer Review
  • Publishing Process
  • Submit Manuscript

Quick links

  • About Us
  • Guidelines
  • Journal List
  • Contact Us

Resources

  • Editors
  • Blogs
  • Membership
  • Ethics & Policies

get in touch

Enter your E-mail and we'll send you more information.

Content of this site is available under Commons Attribution 4.0 License Copyright © 2020 Pubtexto - All Right Reserved

  • Follow us: